NeuroPace (NPCE) Cost of Revenue (2020 - 2026)

NeuroPace has reported Cost of Revenue for 7 years, with the latest figure at $3.9 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 19.22% year-over-year to $3.9 million in Q2 2026; TTM through Jun 2026 was $20.1 million, a 3.86% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, up 9.34% from the prior year.
• Cost of Revenue was $3.9 million for Q2 2026 at NeuroPace, down from $4.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $6.2 million in Q3 2025, with the low at $2.7 million in Q2 2022.
• Average Cost of Revenue over 5 years is $4.4 million, with a median of $4.3 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue jumped 65.98% in 2023, then plunged 35.81% in 2025.
• Over 5 years, Cost of Revenue stood at $4.0 million in 2022, then grew by 12.07% to $4.5 million in 2023, then climbed by 18.16% to $5.3 million in 2024, then rose by 13.87% to $6.0 million in 2025, then sank by 34.78% to $3.9 million in 2026.
• The last three Cost of Revenue figures came in at $3.9 million (Q2 2026), $4.0 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.